DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease

Abstract

Human noroviruses are the primary causative agents of acute gastroenteritis and a pressing public health burden worldwide. There are currently no vaccines or small molecule therapeutics available for the treatment or prophylaxis of norovirus infections. Norovirus 3CL protease plays a vital role in viral replication by generating structural and nonstructural proteins via the cleavage of the viral polyprotein. Thus, molecules that inhibit the viral protease may have potential therapeutic value. Herein we describe the structure-based design, synthesis, and in vitro and cell-based evaluation of the first class of oxadiazole-based, permeable macrocyclic inhibitors of norovirus 3CL protease.

Authors:
 [1];  [2];  [1];  [1];  [1];  [3];  [4];  [5];  [4];  [2];  [1]
  1. Wichita State Univ., Wichita, KS (United States)
  2. Kansas State Univ., Manhattan, KS (United States). College of Veterinary Medicine
  3. LiS Consulting, Lawrence, KS (United States)
  4. Univ. of Kansas, Lawrence, KS (United States)
  5. Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS), IMCA-CAT; Hauptman-Woodward Medical Research Inst., Argonne, IL (United States)
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
USDOE Office of Science (SC), Basic Energy Sciences (BES); National Institutes of Health (NIH); National Center for Research Resources; National Institute of General Medical Sciences (NIGMS); Industrial Macromolecular Crystallography Association
OSTI Identifier:
1248389
Grant/Contract Number:  
R01 AI109039; 5P20RR017708-10; 8P20GM103420-10; AC02-06CH11357
Resource Type:
Accepted Manuscript
Journal Name:
Journal of Medicinal Chemistry
Additional Journal Information:
Journal Volume: 59; Journal Issue: 5; Journal ID: ISSN 0022-2623
Publisher:
American Chemical Society (ACS)
Country of Publication:
United States
Language:
ENGLISH
Subject:
60 APPLIED LIFE SCIENCES; Peptides and proteins; Inhibitors; Noncovalent interactions; Permeability; Macrocycles

Citation Formats

Damalanka, Vishnu C., Kim, Yunjeong, Alliston, Kevin R., Weerawarna, Pathum M., Galasiti Kankanamalage, Anushka C., Lushington, Gerald H., Mehzabeen, Nurjahan, Battaile, Kevin P., Lovell, Scott, Chang, Kyeong-Ok, and Groutas, William C. Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease. United States: N. p., 2016. Web. doi:10.1021/acs.jmedchem.5b01464.
Damalanka, Vishnu C., Kim, Yunjeong, Alliston, Kevin R., Weerawarna, Pathum M., Galasiti Kankanamalage, Anushka C., Lushington, Gerald H., Mehzabeen, Nurjahan, Battaile, Kevin P., Lovell, Scott, Chang, Kyeong-Ok, & Groutas, William C. Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease. United States. https://doi.org/10.1021/acs.jmedchem.5b01464
Damalanka, Vishnu C., Kim, Yunjeong, Alliston, Kevin R., Weerawarna, Pathum M., Galasiti Kankanamalage, Anushka C., Lushington, Gerald H., Mehzabeen, Nurjahan, Battaile, Kevin P., Lovell, Scott, Chang, Kyeong-Ok, and Groutas, William C. Mon . "Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease". United States. https://doi.org/10.1021/acs.jmedchem.5b01464. https://www.osti.gov/servlets/purl/1248389.
@article{osti_1248389,
title = {Oxadiazole-Based Cell Permeable Macrocyclic Transition State Inhibitors of Norovirus 3CL Protease},
author = {Damalanka, Vishnu C. and Kim, Yunjeong and Alliston, Kevin R. and Weerawarna, Pathum M. and Galasiti Kankanamalage, Anushka C. and Lushington, Gerald H. and Mehzabeen, Nurjahan and Battaile, Kevin P. and Lovell, Scott and Chang, Kyeong-Ok and Groutas, William C.},
abstractNote = {Human noroviruses are the primary causative agents of acute gastroenteritis and a pressing public health burden worldwide. There are currently no vaccines or small molecule therapeutics available for the treatment or prophylaxis of norovirus infections. Norovirus 3CL protease plays a vital role in viral replication by generating structural and nonstructural proteins via the cleavage of the viral polyprotein. Thus, molecules that inhibit the viral protease may have potential therapeutic value. Herein we describe the structure-based design, synthesis, and in vitro and cell-based evaluation of the first class of oxadiazole-based, permeable macrocyclic inhibitors of norovirus 3CL protease.},
doi = {10.1021/acs.jmedchem.5b01464},
journal = {Journal of Medicinal Chemistry},
number = 5,
volume = 59,
place = {United States},
year = {Mon Feb 08 00:00:00 EST 2016},
month = {Mon Feb 08 00:00:00 EST 2016}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 20 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis
journal, August 2014


Norovirus Disease in the United States
journal, August 2013

  • Hall, Aron J.; Lopman, Ben A.; Payne, Daniel C.
  • Emerging Infectious Diseases, Vol. 19, Issue 8
  • DOI: 10.3201/eid1908.130465

Norovirus Gastroenteritis in Immunocompromised Patients
journal, November 2012

  • Bok, Karin; Green, Kim Y.
  • New England Journal of Medicine, Vol. 367, Issue 22
  • DOI: 10.1056/NEJMra1207742

Norovirus
journal, January 2015

  • Robilotti, Elizabeth; Deresinski, Stan; Pinsky, Benjamin A.
  • Clinical Microbiology Reviews, Vol. 28, Issue 1
  • DOI: 10.1128/CMR.00075-14

New strains of norovirus and the mystery of viral gastroenteritis epidemics
journal, September 2013

  • Lee, B. E.; Pang, X. -L.
  • Canadian Medical Association Journal, Vol. 185, Issue 16
  • DOI: 10.1503/cmaj.130426

Noroviruses: The Perfect Human Pathogens?
journal, May 2012


Noroviruses: epidemiology, immunity and prospects for prevention
journal, January 2015

  • Pringle, Kimberly; Lopman, Benjamin; Vega, Everardo
  • Future Microbiology, Vol. 10, Issue 1
  • DOI: 10.2217/fmb.14.102

Human norovirus culture in B cells
journal, October 2015

  • Jones, Melissa K.; Grau, Katrina R.; Costantini, Veronica
  • Nature Protocols, Vol. 10, Issue 12
  • DOI: 10.1038/nprot.2015.121

The molecular pathology of noroviruses: Norovirus pathology
journal, December 2014

  • Karst, Stephanie M.; Zhu, Shu; Goodfellow, Ian G.
  • The Journal of Pathology, Vol. 235, Issue 2
  • DOI: 10.1002/path.4463

Norovirus gene expression and replication
journal, November 2013

  • Thorne, L. G.; Goodfellow, I. G.
  • Journal of General Virology, Vol. 95, Issue Pt_2
  • DOI: 10.1099/vir.0.059634-0

Processing of Norwalk virus nonstructural proteins by a 3C-like cysteine proteinase
journal, April 2003


A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor
journal, January 2011

  • Hussey, Robert J.; Coates, Leighton; Gill, Raj S.
  • Biochemistry, Vol. 50, Issue 2
  • DOI: 10.1021/bi1008497

Structure-based design and functional studies of novel noroviral 3C protease chimaeras offer insights into substrate specificity
journal, December 2014

  • Herod, Morgan R.; Prince, Cynthia A.; Skilton, Rachel J.
  • Biochemical Journal, Vol. 464, Issue 3
  • DOI: 10.1042/BJ20140959

On the size of the active site in proteases. I. Papain
journal, April 1967

  • Schechter, Israel; Berger, Arieh
  • Biochemical and Biophysical Research Communications, Vol. 27, Issue 2, p. 157-162
  • DOI: 10.1016/S0006-291X(67)80055-X

Structural Basis of Substrate Specificity and Protease Inhibition in Norwalk Virus
journal, January 2013

  • Muhaxhiri, Z.; Deng, L.; Shanker, S.
  • Journal of Virology, Vol. 87, Issue 8
  • DOI: 10.1128/JVI.02869-12

Substrate specificity of the Norwalk virus 3C-like proteinase
journal, October 2002


Characterization of the norovirus 3C-like protease
journal, June 2005


2013 FDA drug approvals
journal, January 2014

  • Mullard, Asher
  • Nature Reviews Drug Discovery, Vol. 13, Issue 2
  • DOI: 10.1038/nrd4239

Emerging principles in protease-based drug discovery
journal, September 2010

  • Drag, Marcin; Salvesen, Guy S.
  • Nature Reviews Drug Discovery, Vol. 9, Issue 9
  • DOI: 10.1038/nrd3053

Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease
journal, September 2011

  • Tiew, Kok-Chuan; He, Guijia; Aravapalli, Sridhar
  • Bioorganic & Medicinal Chemistry Letters, Vol. 21, Issue 18
  • DOI: 10.1016/j.bmcl.2011.07.016

Potent inhibition of norovirus 3CL protease by peptidyl α-ketoamides and α-ketoheterocycles
journal, July 2012

  • Mandadapu, Sivakoteswara Rao; Weerawarna, Pathum M.; Gunnam, Mallikarjuna Reddy
  • Bioorganic & Medicinal Chemistry Letters, Vol. 22, Issue 14
  • DOI: 10.1016/j.bmcl.2012.05.055

Potent inhibition of norovirus by dipeptidyl α-hydroxyphosphonate transition state mimics
journal, November 2013

  • Mandadapu, Sivakoteswara Rao; Gunnam, Mallikarjuna Reddy; Galasiti Kankanamalage, Anushka C.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 21
  • DOI: 10.1016/j.bmcl.2013.08.073

Broad-Spectrum Antivirals against 3C or 3C-Like Proteases of Picornaviruses, Noroviruses, and Coronaviruses
journal, August 2012

  • Kim, Y.; Lovell, S.; Tiew, K. -C.
  • Journal of Virology, Vol. 86, Issue 21
  • DOI: 10.1128/JVI.01348-12

Macrocyclic inhibitors of 3C and 3C-like proteases of picornavirus, norovirus, and coronavirus
journal, July 2013

  • Mandadapu, Sivakoteswara Rao; Weerawarna, Pathum M.; Prior, Allan M.
  • Bioorganic & Medicinal Chemistry Letters, Vol. 23, Issue 13
  • DOI: 10.1016/j.bmcl.2013.05.021

Structure-Guided Design and Optimization of Dipeptidyl Inhibitors of Norovirus 3CL Protease. Structure–Activity Relationships and Biochemical, X-ray Crystallographic, Cell-Based, and In Vivo Studies
journal, March 2015

  • Galasiti Kankanamalage, Anushka C.; Kim, Yunjeong; Weerawarna, Pathum M.
  • Journal of Medicinal Chemistry, Vol. 58, Issue 7
  • DOI: 10.1021/jm5019934

Pharmacokinetics of Biotech Drugs: Peptides, Proteins and Monoclonal Antibodies
journal, September 2009


The Future of Peptide-based Drugs
journal, December 2012

  • Craik, David J.; Fairlie, David P.; Liras, Spiros
  • Chemical Biology & Drug Design, Vol. 81, Issue 1
  • DOI: 10.1111/cbdd.12055

Macrocycles in new drug discovery
journal, July 2012

  • Mallinson, Jamie; Collins, Ian
  • Future Medicinal Chemistry, Vol. 4, Issue 11
  • DOI: 10.4155/fmc.12.93

Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery
journal, April 2011

  • Marsault, Eric; Peterson, Mark L.
  • Journal of Medicinal Chemistry, Vol. 54, Issue 7
  • DOI: 10.1021/jm1012374

Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
journal, September 2013

  • Giordanetto, Fabrizio; Kihlberg, Jan
  • Journal of Medicinal Chemistry, Vol. 57, Issue 2
  • DOI: 10.1021/jm400887j

Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space
journal, January 2011

  • Alex, Alexander; Millan, David S.; Perez, Manuel
  • MedChemComm, Vol. 2, Issue 7
  • DOI: 10.1039/c1md00093d

Testing the Conformational Hypothesis of Passive Membrane Permeability Using Synthetic Cyclic Peptide Diastereomers
journal, March 2006

  • Rezai, Taha; Yu, Bin; Millhauser, Glenn L.
  • Journal of the American Chemical Society, Vol. 128, Issue 8
  • DOI: 10.1021/ja0563455

Macrocycles Mimic The Extended Peptide Conformation Recognized By Aspartic, Serine, Cysteine and Metallo Proteases
journal, July 2001


Proteases Universally Recognize Beta Strands In Their Active Sites
journal, March 2005

  • Tyndall, Joel D. A.; Nall, Tessa; Fairlie, David P.
  • Chemical Reviews, Vol. 105, Issue 3
  • DOI: 10.1021/cr040669e

Update 1 of: Proteases Universally Recognize Beta Strands In Their Active Sites
journal, June 2010

  • Madala, Praveen K.; Tyndall, Joel D. A.; Nall, Tessa
  • Chemical Reviews, Vol. 110, Issue 6
  • DOI: 10.1021/cr900368a

Mild and convenient one-pot synthesis of 1,3,4-oxadiazoles
journal, September 2010


Design and Synthesis of Cyclic Inhibitors of Matrix Metalloproteinases and TNF-α Production
journal, May 1998

  • Xue, Chu-Biao; He, Xiaohua; Roderick, John
  • Journal of Medicinal Chemistry, Vol. 41, Issue 11
  • DOI: 10.1021/jm970849z

Characterization and inhibition of norovirus proteases of genogroups I and II using a fluorescence resonance energy transfer assay
journal, February 2012


Structural and dynamics characterization of norovirus protease: NMR Study of Norovirus Protease
journal, January 2013

  • Takahashi, Daisuke; Hiromasa, Yasuaki; Kim, Yunjeong
  • Protein Science, Vol. 22, Issue 3
  • DOI: 10.1002/pro.2215

Automatic indexing of rotation diffraction patterns
journal, February 1988


An introduction to data reduction: space-group determination, scaling and intensity statistics
journal, March 2011

  • Evans, Philip R.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S090744491003982X

Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206

PHENIX: a comprehensive Python-based system for macromolecular structure solution
journal, January 2010

  • Adams, Paul D.; Afonine, Pavel V.; Bunkóczi, Gábor
  • Acta Crystallographica Section D Biological Crystallography, Vol. 66, Issue 2, p. 213-221
  • DOI: 10.1107/S0907444909052925

Developments in the CCP 4 molecular-graphics project
journal, November 2004

  • Potterton, Liz; McNicholas, Stuart; Krissinel, Eugene
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12
  • DOI: 10.1107/S0907444904023716

Improved R-factors for diffraction data analysis in macromolecular crystallography
journal, April 1997

  • Diederichs, Kay; Karplus, P. Andrew
  • Nature Structural Biology, Vol. 4, Issue 4
  • DOI: 10.1038/nsb0497-269

Global indicators of X-ray data quality
journal, April 2001


Linking Crystallographic Model and Data Quality
journal, May 2012


Resolving Some Old Problems in Protein Crystallography
journal, May 2012


Works referencing / citing this record:

Norovirus antivirals: Where are we now?
journal, December 2018

  • Netzler, Natalie E.; Enosi Tuipulotu, Daniel; White, Peter A.
  • Medicinal Research Reviews, Vol. 39, Issue 3
  • DOI: 10.1002/med.21545

Putative structural rearrangements associated with the interaction of macrocyclic inhibitors with norovirus 3CL protease
journal, April 2019

  • Galasiti Kankanamalage, Anushka C.; Weerawarna, Pathum M.; Rathnayake, Athri D.
  • Proteins: Structure, Function, and Bioinformatics, Vol. 87, Issue 7
  • DOI: 10.1002/prot.25682

Oxadiazole grafts in peptide macrocycles
journal, October 2016

  • Frost, John R.; Scully, Conor C. G.; Yudin, Andrei K.
  • Nature Chemistry, Vol. 8, Issue 12
  • DOI: 10.1038/nchem.2636

Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
journal, February 2019

  • Chang, Kyeong-Ok; Kim, Yunjeong; Lovell, Scott
  • Viruses, Vol. 11, Issue 2
  • DOI: 10.3390/v11020197

Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future
journal, May 2018


Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
journal, February 2019

  • Chang, Kyeong-Ok; Kim, Yunjeong; Lovell, Scott
  • Viruses, Vol. 11, Issue 2
  • DOI: 10.3390/v11020197